Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal dexmedetomidine PK in infants undergoing cardiac catheterization
ChiCTR-OPC-16008589Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in Cardiovascular Malformation (CVM), sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: Early pharmacokinetics of intranasal dexmedetomidine. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR-OPC-16008589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008589.